Eli Lilly obesity drug Zepbound led to 47% greater relative weight loss compared to Wegovy in a head-to-head clinical trial. The results could help Lilly differentiate its product from Novo Nordisk’s in the increasingly competitive market of obesity medications.
Researchers explored how immune checkpoint inhibitors interact with immune cells in arterial plaques.
Data from SURMOUNT-5, a head-to-head trial, demonstrate tirzepatide offered greater weight loss benefits than semaglutide.
Women who gave birth after infertility without receiving fertility treatments had an elevated risk of developing SARDs, such as lupus.
Objective To prospectively investigate the associations between dark, milk, and total chocolate consumption and risk of type 2 diabetes (T2D) in three US cohorts. Design…
The U.K. will soon offer Eli Lilly’s Mounjaro for people with obesity — but only to a small share of those medically eligible, and alongside…
Google’s Genie 2 creates small 3D game worlds from just an AI prompt, complete with physics, reflections, and even NPCs.
The U.K. will soon offer Eli Lilly’s Mounjaro for people with obesity — but only to a small share of those medically eligible, and alongside…
Elon Musk’s controversial electric truck may have dug its own box-shaped grave.
Case report: A 30-year-old patient experiences progressive sensory loss starting with his hands. Collaboration between Cleveland Clinic neurologists and rheumatologists leads to diagnosis and treatment.
He has also claimed Wi-Fi causes cancer and that antidepressants are to blame for mass shootings
